Case Report · pages 186–187
Rifampicin Induced Thrombocytopenia:A Case Report
Cite this article
N. S. Neki. Rifampicin Induced Thrombocytopenia:A Case Report. J Int Med Sci Acad. 2011;24(4):186–187.
Opening of the article
Rifampicin is an essential drug in the treatment regimen for tuberculosis. It is generally well tolerated. But very rarely it can cause serious adverse reactions in the form of acute renal failure and thrombocytopenia. A case of acute thrombocytopenia occurring in a patient on Rifampicin for the treatment of pulmonary tuberculosis is being reported here. Correspondence: Prof. N. S. Neki, Professor of Medicine, Govt. Medical College and Guru Nanak Dev Hospital, Amritsar, India e-mail: dr nsneki_123@ yahoo.com in the form of nausea, vomiting and rash, very rarely it may cause life threatening side effects like acute renal failure and thrombocytopenia1, 2.
